ProQR Therapeutics N.V. buy Bank of America Co.
Start price
20.08.26
/
50%
€2.04
Target price
20.08.27
€6.85
Performance (%)
-2.01%
Price
21.08.26
€1.90
Summary
This prediction is currently active. With a performance of -2.01%, the BUY prediction by Bank_of_America_Co_ is trending in the wrong direction. This prediction currently runs until 20.08.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| ProQR Therapeutics N.V. | -2.01% |
| iShares Core DAX® | -1.283% |
| iShares Nasdaq 100 | -3.338% |
| iShares Nikkei 225® | -4.286% |
| iShares S&P 500 | -2.311% |
Comments by Bank_of_America_Co_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (PRQR) is now covered by Bank of America Corporation. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat

